Stocks and Investing
Stocks and Investing
Mon, December 13, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sun, December 12, 2021
[ 12:00 AM ] - WOPRAI
Fri, December 10, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Andrew Berens Maintained (ZNTL) at Buy with Increased Target to $89 on, Dec 10th, 2021
Andrew Berens of SVB Leerink, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Increased Target from $84 to $89 on, Dec 10th, 2021.
Andrew has made no other calls on ZNTL in the last 4 months.
There are 4 other peers that have a rating on ZNTL. Out of the 4 peers that are also analyzing ZNTL, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Andrew
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $120 on, Thursday, November 11th, 2021
- Robert Driscoll of "Wedbush" Maintained at Buy with Increased Target to $89 on, Wednesday, October 27th, 2021
- Bradley Canino of "Stifel" Initiated at Strong Buy and Held Target at $84 on, Thursday, September 30th, 2021
- Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $90 on, Wednesday, September 29th, 2021
Contributing Sources